Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Chronic Obstructive Pulmonary Disease Patient Preferences Survey

1 de diciembre de 2020 actualizado por: Dennis Jensen, Ph.D., McGill University

COPD Patient Preferences, Activities, and Participation Survey

The purpose of this study is to distribute a questionnaire created for individuals living with chronic obstructive pulmonary disease (COPD) to assess their activities, participation, and healthcare and COPD-related research priorities. The data collected will be compared across diagnosed COPD stages and disease severity to determine the extent to which adults with COPD participate in the listed activities and identify their primary research and healthcare related priorities. The questionnaire was originally developed based on past research then verified by a panel of COPD and participation experts; as well as, individuals living with COPD in the form of focus groups. The questionnaire will now be administered to 200 individuals living COPD (50 in each GOLD stage) at three sites across Montreal where clinical data for each participant will be available. This phase will help establish the reliability of the questionnaire.

Descripción general del estudio

Estado

Terminado

Intervención / Tratamiento

Tipo de estudio

De observación

Inscripción (Actual)

200

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

    • Quebec
      • Montreal, Quebec, Canadá, H4A 3J1
        • Montreal Chest Institute of the McGill University Health Center (MUHC)

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

40 años a 90 años (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Método de muestreo

Muestra no probabilística

Población de estudio

Adults living with chronic obstructive pulmonary disease (COPD).

Descripción

Inclusion Criteria:

  • Clinical diagnosis of COPD
  • English or French speaking
  • Patient at one of the three participating sites with medical chart

Exclusion Criteria:

  • No diagnosis of COPD by a healthcare professional
  • Unable to communicate in English or French
  • Unable to provide informed consent
  • No medical chart information at one of the three participating sites

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

Cohortes e Intervenciones

Grupo / Cohorte
Intervención / Tratamiento
Quartile 1 [Mild]
Participants will answer an online survey and their medical chart information will be gathered to compare responses across disease severity.
Quartile 2 [Moderate]
Participants will answer an online survey and their medical chart information will be gathered to compare responses across disease severity.
Quartile 3 [Severe]
Participants will answer an online survey and their medical chart information will be gathered to compare responses across disease severity.
Quartile 4 [Very Severe]
Participants will answer an online survey and their medical chart information will be gathered to compare responses across disease severity.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Number of Participants Who Prioritized Healthcare Topics
Periodo de tiempo: Baseline
Twenty-four healthcare topics were selected once again from a literature and expert panel review, as well as corroborated by individuals living with COPD in five focus groups. Example healthcare topics include: relief of breathlessness; increase maximal amount of exercise individuals living with COPD can do inside and outside their homes; and prevent-lung flare-ups. Participants were asked to indicate their preference of the topics by assigning a percentage of their time, in increments of 10%, to the various healthcare topics, for a total of 100% of their time. For the 24 healthcare topics, individuals could select up to 10 topics (10% times 10 topics, for 100% of their time). The top five topics are presented as the most important topics for the participants and are indicative of areas of focus for future healthcare and research. The top five were presented in accordance to the request from the working group who developed the survey and reviewed the results.
Baseline
Number of Participants Who Prioritized Research Topics
Periodo de tiempo: Baseline
Individuals were asked to indicate their research priorities from a list of research topics using a modified willingness-to-pay method (Kawata et al., 2014). The willingness-to-pay method allows individuals to assign preference to various topics by assigning a percentage of funds to the topic. A list of 22 research topics (e.g., to relieve breathlessness in individuals living with COPD, to increase access to lung transplantations) was created for this study through a literature review, expert consultation, and five focus groups with individuals living with COPD (n=23, 27% women). Individuals were asked to assign a percentage of funds, in increments of 10% of funding, to the 22 COPD research topics. Participants could assign anywhere between 10% of funding to 100% of funding to the topics. The top five were presented in accordance to the request from the working group who developed the survey and reviewed the results.
Baseline
Number of Participants Who Were Not Satisfied With Their Participation in Daily and Social Activities
Periodo de tiempo: Baseline

Participants will answer questions about their participation in 26 daily activities, as well as their desire to participate in each of the 26 daily activities. This is a measure of those who indicated they wanted to increase their participation. 10 of the 26 activities and their outcome measures are listed below.

Activity 1: Walking from one place to another outside of your home on a flat surface.

Activity 2: Moving from one place to another using motorized transportation.

Activity 3: Climbing two or more flights of stairs.

Activity 4: Walking up a hill.

Activity 5: Participating in regular exercise.

Activity 6: Walking from one place to another in your home.

Activity 7: Carrying light objects on a flat surface.

Activity 8: Carrying heavy objects on a flat surface.

Activity 9: Carrying-out low intensity physical activities

Baseline

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Forced Expiratory Volume in 1-sec (FEV1)
Periodo de tiempo: Baseline
Individuals forced expiratory volume in 1-sec (FEV1) as assessed by spirometry
Baseline
FEV1/FVC
Periodo de tiempo: Baseline
Individuals FEV1-to-forced vital capacity (FVC) ratio
Baseline
Modified Medical Research Council Questionnaire on Breathlessness
Periodo de tiempo: Baseline
Self-reported intensity of activity related breathlessness as assessed by the modified Medical Research Council (mMRC) dyspnea scale (0-4). This questionnaire was used to measure participants' breathlessness burden using a single item scale from 0 to 4, where a score of 0-1 indicated mild breathlessness and 2-4 indicated increased breathlessness.
Baseline
COPD Assessment Test
Periodo de tiempo: Baseline
This questionnaire measure the impact COPD is having on well being and daily life. The CAT is an eight-item semantic differential scale from 0 to 5, where 0 is no impact and 5 is extremely impactful. Items include: I never cough| I cough all the time, I have no phlegm (mucus) in my chest at all | My chest is completely full of phlegm (mucus), My chest does not feel tight at all | My chest feels very tight, When I walk up a hill or one flight of stairs, I am not breathless | When I walk up a hill or one flight of stairs, I am very breathless, I am not limited doing any activities at home| I am very limited doing activities at home, I am confident leaving my home despite my lung condition| I am not at all confident leaving my home because of my lung condition, I sleep soundly | I don't sleep soundly because of my lung condition, I have lots of energy I have no energy at all. Participants' scores were totaled and a score of ≥ 10 indicated higher than normal burden of disease.
Baseline
Godin Leisure Time Physical Activity Questionnaire
Periodo de tiempo: Baseline
Self-reported physical activity levels measured in length of bouts over the previous 7 days to determine physical activity frequency.
Baseline
Satisfaction of Life Questionnaire
Periodo de tiempo: Baseline
This 5 item questionnaire was used to measure participants' level of life satisfaction. The higher the score, the higher the sense of life satisfaction. A score from 5-9 indicated extremely dissatisfied, 10-14 is dissatisfied, 15-19 indicated slightly below average life satisfaction. 20-24 is the average score, 25-29 is a high score indicative of higher life satisfaction and a score between 30-35 is a very high score and represent very high life satisfaction.
Baseline
Number of Participants With Exacerbations Due to COPD in the Preceding 12 Months
Periodo de tiempo: baseline
An exacerbation was defined as a change in medication due to a COPD exacerbation (i.e., the prescription of prednisone or a medical action plan) as indicated in the medical chart or hospital admission due to a COPD exacerbation.
baseline

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Colaboradores

Investigadores

  • Investigador principal: Shane N Sweet, Ph.D., McGill University

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio

1 de noviembre de 2016

Finalización primaria (Actual)

1 de octubre de 2017

Finalización del estudio (Actual)

12 de diciembre de 2018

Fechas de registro del estudio

Enviado por primera vez

26 de abril de 2016

Primero enviado que cumplió con los criterios de control de calidad

18 de noviembre de 2016

Publicado por primera vez (Estimar)

22 de noviembre de 2016

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

24 de diciembre de 2020

Última actualización enviada que cumplió con los criterios de control de calidad

1 de diciembre de 2020

Última verificación

1 de diciembre de 2020

Más información

Términos relacionados con este estudio

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Ensayos clínicos sobre Patient Survey

3
Suscribir